期刊文献+

柴胡-黄芩药对防治新型冠状病毒肺炎网络药理学分子机制研究 被引量:8

Molecular Mechanism Research of Chaihu(Bupleuri Radix)and Huangqin(Radix Scutellariae)Couplet in Treating Corona Virus Disease 2019 Based on Network Pharmacology
下载PDF
导出
摘要 目的基于网络药理学研究柴胡-黄芩药对防治新型冠状病毒肺炎的药物成分,预测作用靶点,并探讨其潜在的作用机制。方法通过中药系统药理学数据库(TCMSP)收集柴胡-黄芩药对的药物成分及相应作用靶点;运用STRING数据库与Cytoscape软件构建"药物成分-靶点"网络和蛋白相互作用网络;通过ClueGO对靶点的基因本体(GO)及KEGG通路进行富集分析。结果以口服生物利用度(OB)和类药性(DL)两个参数为标准,共筛选得到52个药物成分;疾病相关的作用靶点共刷选出41个;通过富集分析得出多条相关的基因本体(GO)功能和KEGG通路。结论该研究结果初步预测了柴胡-黄芩药防治新型冠状病毒肺炎的的主要药物成分、靶点和信号通路,为进一步开展其作用机制的研究提供了新思路和新方向。 Objective To analyze the effective active ingredients of Chaihu(Bupleuri Radix)and Huangqin(Radix Scutellariae)couplet in the treatment of corona virus disease 2019(COVID-19)based on network pharmacology,in order to predict their targets and explore the potential mechanism.Methods Herb ingredients and their corresponding targets were collected from traditional Chinese medicine system pharmacology database(TCMSP).Herb ingredients-targets network and protein interacting network were built by STRING database and Cytoscape software.ClueGO was used to enrich the gene ontology and KEGG pathway of core targets.Results The 52 herb ingredients were screened out based on two parameters[oral bioavailability(OB)and drug-like(DL)].There were 41 targets selected for the research,and a number of corresponding gene ontology(GO)functions and Kyoto Encyclopedin of Genes and Genomes(KEGG)pathways were enriched.Conclusion The results of this study preliminarily predicted the main drug components,targets and signaling pathways of Chaihu(Bupleuri Radix)and Huangqin(Radix Scutellariae)couplet for COVID-19,and provided new ideas and directions for further research on the mechanism of Chaihu(Bupleuri Radix)and Huangqin(Radix Scutellariae)couplet.
作者 束沛 郑忻 席瑞 郑炜东 曲妮妮 SHU Pei;ZHENG Xin;XI Rui;ZHENG Weidong;QU Nini(Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110032,Liaoning,China)
出处 《辽宁中医药大学学报》 CAS 2021年第1期94-99,共6页 Journal of Liaoning University of Traditional Chinese Medicine
基金 国家中医药管理局中医临床诊疗指南制修订项目(SATCM-2015-BZ[037]) 新型冠状病毒肺炎中医药方案的验证、应用和推广研究(2020JH2/10300004)。
关键词 柴胡 黄芩 药对 新型冠状病毒肺炎 分子机制 网络药理学 Chaihu(Bupleuri Radix) Huangqin(Radix Scutellariae) couplet medicines corona virus disease 2019 molecular mechanism network pharmacology
  • 相关文献

参考文献10

二级参考文献117

  • 1孙婷婷,袁野,于红艳,刘墨祥,李吉萍.板蓝根活性组分预防肥胖作用及机制研究[J].中国现代应用药学,2013,30(1):10-15. 被引量:6
  • 2沈丹华,廖晓耘,刘艳丽,王华,虞有智.胎盘部位过度反应及胎盘部位结节的临床病理分析[J].中华病理学杂志,2004,33(5):441-444. 被引量:23
  • 3Jamaluddin M, Wang S, Boldogh I, et al. TNF-alpha-induced NF-kappaB/RelA Ser (276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway [ J ]. Cell Signal, 2007,19 ( 7 ) : 1419-1433.
  • 4Wang Y, Mo X, Piper M G, et al. MoCSF induces monocyte survival by activating NF-kappaB p65 phosphorylation at Ser276 via protein kinase C [ J ]. PLoS One, 2011, 6 (12) : e28081.
  • 5Nihira K, Ando Y, Yamaguchi T, et al. Pim-1 controls NF- kappaB signalling by stabilizing RelA/p65 [ J ]. Cell Death Differ, 2010,17(4) :689-698.
  • 6Mattioli I, Geng H, Sebald A, et al. Inducible phosphorylation of NF-kappa B p65 at serine 468 hy T cell eostimulation is mediated by IKK epsilon [ J ]. J Biol Chem, 2006,281 (10) : 6175-6183.
  • 7Adli M, Baldwin A S. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser536 p65/RelA phosphorylation [ J ]. J Biol Chem, 2006,281( 37 ) : 26976-26984.
  • 8Hoberg J E, Popko A E, Ramsey C S, et al. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300[J]. Mol Cell Biol, 2006,26(2) :457-471.
  • 9Msaki A, Sanchez A M, Koh L F, et al. The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration [ J]. Mol Biol Cell, 2011 , 22 ( 17 ) :3032-3040.
  • 10Geng H, Wittwer T, Dittrich-Breiholz O, et al. Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMDl-dependent ubiquitination and target gene-specific proteasomal elimination [J]. EMBO Rep, 2009, 10(4) :381-386.

共引文献369

同被引文献172

引证文献8

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部